A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer's disease.
about
A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer's disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
A novel quantification-driven ...... marker of Alzheimer's disease.
@en
A novel quantification-driven ...... marker of Alzheimer's disease.
@nl
type
label
A novel quantification-driven ...... marker of Alzheimer's disease.
@en
A novel quantification-driven ...... marker of Alzheimer's disease.
@nl
prefLabel
A novel quantification-driven ...... marker of Alzheimer's disease.
@en
A novel quantification-driven ...... marker of Alzheimer's disease.
@nl
P2093
P2860
P50
P1433
P1476
A novel quantification-driven ...... marker of Alzheimer's disease.
@en
P2093
Ekaterina Mirgorodskaya
Floor Duits
Johan Gobom
Karl Hansson
Rahil Dahlén
P2860
P2888
P356
10.1038/S41598-017-13831-0
P407
P50
P577
2017-10-17T00:00:00Z